Top

Sleep and Breathing

Published in:

01-03-2012 | Letter to the Editors

CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas

Authors: Charalampos Mermigkis, Demetrios Mermigkis, Georgios Varouchakis, Sophia Schiza

Published in: Sleep and Breathing | Issue 1/2012

Excerpt

Dear Editor: …

Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D (2010) How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 14(4):387–390. doi:10.1007/s11325-010-0336-5 PubMedCrossRef

Ruhle KH (2010) Commentary on how common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al. Sleep Breath 14(4):289. doi:10.1007/s11325-010-0341-8 PubMedCrossRef

Lancaster LH, Mason WR, Parnell JA, Rice TW, Loyd JE, Milstone AP, Collard HR, Malow BA (2009) Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 136:772–778PubMedCrossRef

Rasche K, Orth M (2009) Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol Suppl 5:13–14

Mermigkis C, Chapman J, Golish J, Mermigkis D, Budur K, Kopanakis A, Polychronopoulos V, Burgess R, Foldvary-Schaefer N (2007) Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis. Lung 185:173–178PubMedCrossRef

Mermigkis C, Stagaki E, Amfilochiou A, Polychronopoulos V, Korkonikitas P, Mermigkis D, Bregou M, Kouris N, Bouros D (2009) Sleep quality and associated daytime consequences in patients with idiopathic pulmonary fibrosis. Med Princ Pract 18:10–11PubMedCrossRef

Krishnan V, McCormack MC, Mathai SC, Agarwal S, Richardson B, Horton MR, Polito AJ, Collop NA, Danoff SK (2008) Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest 134:693–698PubMedCrossRef

Djonlagic I, Malhotra A (2010) A risk of stroke from sleep apnea in men to women. Expert Rev Neurother 10:1267–1271PubMedCrossRef

Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J (2006) Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry 14:176–180PubMedCrossRef

10.

Bassetti CL, Milanova M, Gugger M (2006) Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37:967–972PubMedCrossRef

11.

Chrousos GA, Kattah JC, Beck RW, Cleary PA (1993) Side effects of glucocorticoid treatment. experience of the optic neuritis treatment trial. JAMA 269:2110–2112PubMedCrossRef

12.

Lozada F, Silverman S, Migliorati C (1984) Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases. J Am Dent Assoc 109:269–270PubMed

13.

Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S (2009) Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 5:305–309PubMed

14.

Kohler M, Bloch KE, Stradling JR (2009) Pharmacological approaches to the treatment of obstructive sleep apnoea. Expert Opin Investig Drugs 18:647–656PubMedCrossRef

15.

Carley DW, Olopade C, Ruigt GS, Radulovacki M (2007) Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep 30:35–41PubMed

16.

Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada C, Hayes J, Sillery JK, Pope CE, Pellegrini CA (2006) High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 27:136–142PubMedCrossRef

17.

Kuribayashi S, Kusano M, Kawamura O, Shimoyama Y, Maeda M, Hisada T, Ishizuka T, Dobashi K, Mori M (2010) Mechanism of gastroesophageal reflux in patients with obstructive sleep apnea syndrome. Neurogastroenterol Motil 22:611–e172PubMedCrossRef

18.

Shepherd K, Hillman D, Holloway R, Eastwood P (2010) Mechanisms of nocturnal gastroesophageal reflux events in obstructive sleep apnea. (in press) doi:10.1007/s11325-010-0404

19.

Tawk M, Goodrich S, Kinasewitz G, Orr W (2006) The effect of 1 week of continuous positive airway pressure treatment in obstructive sleep apnea patients with concomitant gastroesophageal reflux. Chest 130:1003–1008PubMedCrossRef

Title: CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas
Authors: Charalampos Mermigkis
Demetrios Mermigkis
Georgios Varouchakis
Sophia Schiza
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Sleep and Breathing / Issue 1/2012
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-010-0476-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

The relation between Lp-PLA2 levels with periodic limb movements

Development of a novel chronic intermittent hypoxia chamber

Predictive equations for CPAP titration in OSAS patients

Differential respiratory control of the upper airway and diaphragm muscles induced by 5-HT1A receptor ligands

Is mandatory screening for obstructive sleep apnea with polysomnography in all severely obese patients indicated?

Effects of high altitude training on exercise capacity: fact or myth

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials